Medical Devices; Immunology and Microbiology Devices; Classification of the Simple Point-of-Care Device to Directly Detect SARS–CoV–2 Viral Targets From Clinical Specimens in Near-Patient Settings
RulemakingRuleFDA-2026-N-6238-0001
Comments
0
Awaiting comments
Deadline
--
Net supportiSupport minus oppose · campaigns included
—
Document
Details
The document's own metadata, straight from regulations.gov.
- Posted
- Jun 11, 2026
- Comment period
- Jun 11, 2026 – ?
- Agency
- Food and Drug Administration (FDA)
- FR Doc
- 2026-11739
- CFR
- 21 CFR Part 866
Analysis
Overview
No comments yet.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
No comments match.
